Ignite Creation Date:
2024-05-06 @ 3:11 PM
Last Modification Date:
2024-10-26 @ 1:44 PM
Study NCT ID:
NCT04551053
Status:
TERMINATED
Last Update Posted:
2024-05-10
First Post:
2020-09-11
Brief Title:
To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib LIMBER-304
Sponsor:
Incyte Corporation
Organization:
Incyte Corporation
Organization Data
Organization:
Incyte Corporation
Class:
INDUSTRY
Study ID:
INCB 50465-304LIMBER-304
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Incyte Corporation
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None